Please notice that for the moment, our DNA Purification Systems are reserved for the Danish Healthcare Institutions.
Due to the high number of requests, PentaBase is prioritising the help we can offer accordingly:
-
Danish Healthcare Institutions
-
Foreign Healthcare Institutions
-
Companies (old customers first)
-
Private persons
Danish Healthcare Institutions
Foreign Healthcare Institutions
Companies (old customers first)
Private persons
How PentaBase can help in the fight against coronavirus
The COVID-19 coronavirus disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide and is an acute threat to global health. Using our technologies and knowledge, PentaBase is currently working on several initiatives to support healthcare workers, scientists and patients combating the COVID-19 disease:
SARS-CoV-2 oligonucleotides
PentaBase is a manufacturer of oligonucleotides based on standard and proprietary DNA technologies. We are currently supplying our customers with custom oligonucleotides for SARS-CoV-2 PCR assays based on our proprietary INA® technologies.
SARS-CoV-2 assay
PentaBase is currently developing our own SARS-CoV-2 real-time PCR assay for use on standard real-time PCR equipment expected to be released in the last week of March. Our SARS-CoV-2 assay shows improved sensitivity and specificity compared to assays based on standard DNA thereby reducing the risk of false positive results.
Instruments for SARS-CoV-2 detection
PentaBase is supplying instruments and kits for detection of SARS-CoV-2 including our BasePurifier™ Nucleic Acid Extraction Instrument and our BaseCycler™ Real-time PCR Instrument.